SunSi Estimates Renewable Electrical Energy Capacity of 1.3 MW at Zibo Qilin Fushan

SunSi Energies, an international manufacturer, seller and distributor of energy products and solutions, today announced that it has expanded the project size of its previously announced letter of intent to install one of its proprietary, modular Organic Rankine Cycle systems ("ORC unit") at Zibo Qilin Fushan Iron & Steel Company ("Qilin"), a steel producing company located in the Shandong province of China.

SunSi's subsidiary, TransPacific Energy, Inc., has completed its technical evaluation of the Qilin facility and determined that the Qilin plant has the capacity for four ORC units and can generate up to 1.3-Megawatts of renewable electrical energy. The ORC units use enhanced heat transfer techniques to maximize heat recovery and efficiently convert waste heat directly into renewable electrical energy. Designed to have a useful life of up to 20 years, the four ORC units are collectively expected to generate up to $1.5 million in supplemental electricity per year. SunSi expects to enter into a definitive agreement with Qilin by the end of 2012 which will determine how the annual supplemental energy profits will be allocated between SunSi and Qilin.

David Natan, SunSi's Chief Executive Officer, stated, "The expansion in size of the Qilin project is extremely encouraging. The ability to take waste heat that normally dissipates and pollutes the environment and convert it into a new source of recurring supplemental energy demonstrates the breakthrough nature of our technology. We believe there are thousands of locations worldwide that could realize considerable economic benefits while simultaneously reducing dangerous greenhouse emissions through the use of our ORC systems"

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.